论文部分内容阅读
磺脲类降糖药并联合二甲双胍治疗,仍餐后血糖≥11.1mmol/L患者。分为观察组加用文迪雅4毫克,1/日;对照组加用拜唐苹50毫克,1/日。结果:观察组①2hPG有统计学意义。观察组治疗前后与治疗组之间均呈有意义下降。②TC、TG治疗前后P<0.05有统计学意义。③HDL-C治疗前后P<0.01有统计学意义。④BMI治疗前后P<0.01有统计学意义;对照组治疗前后P<0.01也有统计学意义。结论:观察组在降低2hPG、TC、TG,升高HDL方面优于对照组;而对照组在体重控制方面有优势,但观察并不增加体重。
Sulfonylurea hypoglycemic agents and metformin treatment, still postprandial blood glucose ≥11.1mmol / L patients. Divided into observation group plus Avandia 4 mg, 1 / day; control group plus Beitang Ping 50 mg, 1 / day. Results: Observation group ① 2hPG was statistically significant. Observation group before and after treatment with the treatment group were significantly decreased. ②TC, TG before and after treatment P <0.05 was statistically significant. ③HDL-C before and after treatment, P <0.01 was statistically significant. ④BMI before and after treatment P <0.01 was statistically significant; control group before and after treatment P <0.01 also had statistical significance. Conclusion: The observation group is better than the control group in reducing 2hPG, TC, TG and increasing HDL; while the control group has the advantage in weight control, but the observation does not increase the body weight.